- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05668624
Sustainable Household Energy Adoption in Rwanda (SHEAR) (SHEAR)
Sustainable Household Energy Adoption in Rwanda (SHEAR): Promoting Rural Health With Solar and Natural Gas
Investigators will conduct a randomized controlled trial substituting traditional forms of household energy (biomass for cooking and kerosene for lighting) with liquified petroleum gas (LPG) stoves/fuel and solar power (in areas marker for solar grids by the Government of Rwanda) in rural Rwanda. Eligible households (n=650) using traditional forms of energy will be recruited from eastern Rwanda. In each household, investigators will recruit either one adult female and one adult male or just one adult, and one child (aged 8-15 years). Following baseline health and exposure assessment, a randomized treatment arm (n=250 homes) will receive a full subsidy for LPG fuel and solar power, a control arm (n=250 homes) will continue to use traditional energy, and a random-subsidy arm (n=150 homes) will be randomized to a discounted price (at baseline and every 6-months) for solar and LPG in a pay-as-you-go (PAYG) service model (i.e., pre-pay a desired amount through mobile money). The random subsidy arm will then decide whether or not to cook with the discounted LPG or their traditional stove. Participants will be followed for 3 years with repeated measures of household air pollution (HAP) exposure (48-hour fine particulate matter (PM2.5) and black carbon (BC)), energy use, health, and preferences. Primary health endpoints include blood pressure (BP) in adults and lung-function growth in children; secondary endpoints include BP in children and lung-function change in adults. To complement the trial, the random-subsidy arm will generate policy-relevant information on causal relationships between energy costs, solar and LPG usage, and HAP exposures. The investigators propose 3 aims:
Aim 1. In an ITT framework, investigators will evaluate the effect of a household energy intervention on exposure to HAP and indicators of morbidity separately among Rwandan women, men, and children within n=500 households.
Aim 2. Using exposure-response modeling, investigators will characterize associations between exposure to HAP and indicators of morbidity separately among Rwandan women, men, and children within n=650 households (500 trial households + 150 random subsidy households).
Aim 3. Using a random-encouragement design, investigators will investigate causal relationships between randomized energy costs, measured energy usage, and estimated exposure to HAP among n=400 households (150 random subsidy households + 250 full subsidy treatment arm households).
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Eastern Province
-
Ndego, Eastern Province, Rwanda, 80521
- Field site in Rwanda (Isangano and Karambi)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
This research will recruit and enroll 650 households (250 households in the full subsidy arm; 250 households in the control arm; 150 households in the discount subsidy arm).
The household level inclusion criteria is as follows:
- Home resides in the study area of Isangano and Karambi
- Uses biomass as primary cooking fuel
- Either both an adult male (at least 18 years old) and female (at least 18 years old), or just one adult (at least 18 years old), head(s) of household willing to consent and at least one child between 8 and 15 years of age willing to assent; We will recruit the younger child in families with more than one child between 8-15 years of age. We will also confirm the child is living at home throughout the year and not attending boarding school elsewhere.
- No commercial cooking
- No smoking in the household
Additional participant level inclusion is as follows:
- Not planning to move in 3-year timeframe
- Not currently pregnant (females); Note: If the female becomes pregnant during the study she will not be able to participate in any visits that occur during her pregnancy but she will be able to participate after she has given birth. However, if there is another adult in the household then this will not preclude the other two people (i.e., the other adult and the child) from continuing to participate throughout that time.
Exclusion Criteria:
The household level exclusion criteria is as follows:
- Home resides outside the study area
- Uses clean fuel as primary cooking fuel
- Participants outside the age ranges: Adult male (at least 18 years old) and female (at least 18 years old) heads of household willing to consent and at least one child between 8 and 15 years of age willing to assent
- Conducts commercial cooking
- Smoking members of the household
Additional participant level exclusion is as follows:
- Planning to move in 3-year timeframe
- Currently pregnant (females)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Full Subsidy Arm
This arm receives free LPG and stove for cooking following the baseline measures, for the duration of the 3-year follow-up period.
For those households in Government of Rwanda designated areas for solar microgrids, this arm will also be connected to and provided free access to solar electricity for lighting.
|
LPG stoves/fuel for cooking and solar electricity for lighting
|
|
No Intervention: Control Arm
This arm will remain using traditional forms of energy for cooking and lighting.
|
|
|
Experimental: Discount Subsidy Arm
This arm will be randomized to a discounted price (at baseline and every 6-months during the 3-year study) for solar electricity (in areas marker for solar grids by the Government of Rwanda) and LPG gas in a pay-as-you-go (PAYG) service model (i.e., pre-pay an affordable amount through mobile money, a common form of currency transactions in Rwanda).
For example, this arm will be asked to cook as normal and decide whether or not to cook with the discounted LPG or their traditional stove (i.e., they will not be required to pay for LPG).
|
LPG stoves/fuel for cooking and solar electricity for lighting
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in systolic blood pressure (adults)
Time Frame: Blood pressure will be measured approx. every 6 months for the 3-year follow-up period
|
Blood pressure will be measured approx. every 6 months for the 3-year follow-up period
|
|
Spirometry (children): FEV1 trajectory
Time Frame: Spirometry will be measured approx. every 6 months for the 3-year follow-up period
|
Spirometry will be measured approx. every 6 months for the 3-year follow-up period
|
|
Spirometry (children): FVC trajectory
Time Frame: Spirometry will be measured approx. every 6 months for the 3-year follow-up period
|
Spirometry will be measured approx. every 6 months for the 3-year follow-up period
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in systolic blood pressure (children)
Time Frame: Blood pressure will be measured approx. every 6 months for the 3-year follow-up period
|
Blood pressure will be measured approx. every 6 months for the 3-year follow-up period
|
|
Change in diastolic blood pressure (children)
Time Frame: Blood pressure will be measured approx. every 6 months for the 3-year follow-up period
|
Blood pressure will be measured approx. every 6 months for the 3-year follow-up period
|
|
Spirometry (children): FEV1/FVC trajectory
Time Frame: Spirometry will be measured approx. every 6 months for the 3-year follow-up period
|
Spirometry will be measured approx. every 6 months for the 3-year follow-up period
|
|
Spirometry (children): FEF25-75 trajectory
Time Frame: Spirometry will be measured approx. every 6 months for the 3-year follow-up period
|
Spirometry will be measured approx. every 6 months for the 3-year follow-up period
|
|
Spirometry (children): PEF trajectory
Time Frame: Spirometry will be measured approx. every 6 months for the 3-year follow-up period
|
Spirometry will be measured approx. every 6 months for the 3-year follow-up period
|
|
Change in diastolic blood pressure (adults)
Time Frame: Blood pressure will be measured approx. every 6 months for the 3-year follow-up period
|
Blood pressure will be measured approx. every 6 months for the 3-year follow-up period
|
|
Spirometry (adults): FEV1 change
Time Frame: Lung function will be measured approx. every 1 year for the 3-year follow-up period (adults).
|
Lung function will be measured approx. every 1 year for the 3-year follow-up period (adults).
|
|
Spirometry (adults): FVC change
Time Frame: Lung function will be measured approx. every 1 year for the 3-year follow-up period (adults).
|
Lung function will be measured approx. every 1 year for the 3-year follow-up period (adults).
|
|
Spirometry (adults): FEV1/FVC change
Time Frame: Lung function will be measured approx. every 1 year for the 3-year follow-up period (adults).
|
Lung function will be measured approx. every 1 year for the 3-year follow-up period (adults).
|
|
Spirometry (adults): FEF25-75 change
Time Frame: Lung function will be measured approx. every 1 year for the 3-year follow-up period (adults).
|
Lung function will be measured approx. every 1 year for the 3-year follow-up period (adults).
|
|
Spirometry (adults): PEF change
Time Frame: Lung function will be measured approx. every 1 year for the 3-year follow-up period (adults).
|
Lung function will be measured approx. every 1 year for the 3-year follow-up period (adults).
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2219
- R01ES029995 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Pressure
-
GE HealthcareRecruitingBlood Pressure Measurement | Blood PressureFinland
-
GE HealthcareCompleted
-
Taiwan Biophotonic CorporationCompletedBlood Pressure | Blood Pressure VariabilityTaiwan
-
Université de SherbrookeRecruitingBlood Pressure | Blood Pressure Monitoring, Ambulatory | Blood Pressure, High | Blood Pressure ManagementCanada
-
DongGuk UniversityActive, not recruitingHypertension | Blood Pressure | Ambulatory Blood Pressure | Home Blood Pressure MeasurementKorea, Republic of
-
University of JordanCompletedBlood Pressure | Heart Rate | Airway PressureJordan
-
ROX Medical, Inc.CompletedHypertension | Blood Pressure, High | Blood Pressure, Resistant | Blood Pressure, UncontrolledUnited Kingdom, Netherlands, Belgium
-
Sky LabsSamsung Medical CenterRecruitingHypertension | Blood Pressure | Hypotension | Blood Pressure, High | Blood Pressure, LowKorea, Republic of
-
SE HealthCentre for Aging and Brain Health InnovationCompletedHypertension | Blood Pressure | Hypotension | High Blood Pressure | Low Blood PressureCanada
-
Centre Hospitalier Universitaire VaudoisRecruitingBlood Pressure | Blood Pressure DisordersSwitzerland
Clinical Trials on Clean household energy
-
Partners in HealthUniversity of WarwickCompletedEpilepsy | Hypertension | Diabetes | HIV/AIDS | Malnutrition | Asthma | Tuberculosis | Mental Health Disorder | Family Planning | Antenatal CareMalawi
-
University of CalgaryCanadian Institutes of Health Research (CIHR); British Columbia Farmers' Market... and other collaboratorsCompleted
-
New York City Department of Health and Mental HygieneActive, not recruitingEmergency PreparednessUnited States
-
Temple UniversityPennsylvania Department of HealthCompletedRespiratory Viral Infection | Gastrointestinal InfectionUnited States
-
Peri-Swab, LLCCompleted
-
Papworth Hospital NHS Foundation TrustActive, not recruitingSmoking CessationUnited Kingdom
-
International Care Ministries, PhilippinesCompassion International, United States of AmericaNot yet recruitingChild Development | Child Nutrition, Child Neurobehavioral Development | Academic Attainment | Household and Family | Financial Wellbeing
-
London School of Hygiene and Tropical MedicineNational Institute of Public Health, Cambodia; WaterAidCompletedHospital Infections | Infection Control | Environment, ControlledCambodia
-
St. Luke's Hospital, PennsylvaniaUnknown
-
Stanford UniversityInternational Centre for Diarrhoeal Disease Research, Bangladesh; Thrasher... and other collaboratorsNot yet recruitingInfant Mortality | Child Mortality | Perinatal Mortality | Stillbirth and Neonatal MortalityBangladesh